122 related articles for article (PubMed ID: 2692448)
21. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
[TBL] [Abstract][Full Text] [Related]
22. The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases.
Moul JW; Connelly RR; Perahia B; McLeod DG
J Urol; 1998 Mar; 159(3):935-40. PubMed ID: 9474187
[TBL] [Abstract][Full Text] [Related]
23. [Current assessment of radioimmunological determination (RIA) of prostate acid phosphatase in the diagnosis of prostatic cancer].
Huber PR; Hagmaier V; Scholer A; Lyrer P; Christen P; Wolf T; Kanszo G; Hassel JP; Rutishauser G
Helv Chir Acta; 1981 Aug; 48(3-4):445-52. PubMed ID: 7287483
[TBL] [Abstract][Full Text] [Related]
24. [Immunological colorimetric determination of serum prostatic acid phosphatase activity in patients with prostatic diseases comparing with RIA and Kind-King modified methods].
Hayashi Y; Saionji K; Kitagawa R; Iizuka K; Higurashi H
Rinsho Byori; 1985 Sep; 33(9):1031-40. PubMed ID: 3908752
[No Abstract] [Full Text] [Related]
25. Comparative study of biochemical technique and radioimmunoassay for the measurement of serum prostatic acid phosphatase. Interest in the diagnosis of prostatic cancer?
Canal P; Soula G
Pathol Biol (Paris); 1982 Dec; 30(10):833-6. PubMed ID: 6185909
[TBL] [Abstract][Full Text] [Related]
26. [Clinical evaluation of serum gamma-seminoprotein in patients with prostatic cancer].
Ishihara Y; Hiromoto Y; Higaki Y; Imamura K
Hinyokika Kiyo; 1989 Mar; 35(3):409-13. PubMed ID: 2660507
[TBL] [Abstract][Full Text] [Related]
27. [Measurement of serum PSA by DELFIA PSA kit and its application for mass screening. The Gunma Urological Oncology Study Group].
Imai K; Watanabe K; Higashi H; Shinya H; Okamura K; Matsuo Y; Yazima H; Takezawa Y; Yamanaka H
Hinyokika Kiyo; 1993 Sep; 39(9):807-12. PubMed ID: 7692709
[TBL] [Abstract][Full Text] [Related]
28. Prostatic acid phosphatase: current concepts.
Romas NA
Semin Urol; 1983 Aug; 1(3):177-85. PubMed ID: 6379804
[TBL] [Abstract][Full Text] [Related]
29. [Immunoenzyme assay for prostate-specific acid phosphatase in prostatic cancer].
Bauer HW
Med Welt; 1982 Nov; 33(46):1616-21. PubMed ID: 6185820
[No Abstract] [Full Text] [Related]
30. [The diagnostic value of the radioimmunological estimation of prostatic acid phosphatase. Comparative value of the measurement of enzyme activity (author's transl)].
Tellier JL; Chatal JF; Bourdin S; Auvigne J; Etienne P; Faye R
J Urol (Paris); 1981; 87(3):169-73. PubMed ID: 7240777
[TBL] [Abstract][Full Text] [Related]
31. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
[TBL] [Abstract][Full Text] [Related]
32. [Clinical studies of gamma-seminoprotein in prostatic disease. I. Clinical evaluation of serum gamma-seminoprotein].
Hasegawa S; Nakashima J; Nakashima Y; Nakamura S; Kimura S
Hinyokika Kiyo; 1987 Dec; 33(12):2055-8. PubMed ID: 3329453
[TBL] [Abstract][Full Text] [Related]
33. Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens.
Kuriyama M; Wang MC; Lee CL; Killian CS; Papsidero LD; Inaji H; Loor RM; Lin MF; Nishiura T; Slack NH; Murphy GP; Chu TM
J Natl Cancer Inst; 1982 Jan; 68(1):99-105. PubMed ID: 6172628
[TBL] [Abstract][Full Text] [Related]
34. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?
Tarle M; Kraljić I
Anticancer Res; 1997; 17(3A):1531-4. PubMed ID: 9179191
[TBL] [Abstract][Full Text] [Related]
35. [The significance of free-type PSA and complex-type PSA in patients with prostatic carcinoma--the characteristics of ACS-PSA method compared with that of Delfia- and Eiken-PSA method].
Arai K; Honda M; Hosoya Y; Sumi S; Umeda H; Yoshida K
Rinsho Byori; 1996 Apr; 44(4):345-50. PubMed ID: 8847816
[TBL] [Abstract][Full Text] [Related]
36. [Determination of tumor markers in the diagnosis of prostatic cancer].
Casas Terrón E; Mari Ruiz M; Molina Andreu E
Arch Esp Urol; 1993 Mar; 46(2):99-103. PubMed ID: 7684585
[TBL] [Abstract][Full Text] [Related]
37. [Serum acid phosphatase determined by the radioimmunochemical method (P.A.P.-RIA): its diagnostic value in prostatic cancer].
Marczyńska A; Kulpa J; Adamczyk B; Leńko J
Przegl Lek; 1982 Sep; 39(8):573-6. PubMed ID: 6182582
[No Abstract] [Full Text] [Related]
38. [Prostatic acid phosphatase measured by immunoenzyme assay].
Fuse H; Zama S; Shimazaki J
Hinyokika Kiyo; 1985 Nov; 31(11):1957-64. PubMed ID: 2418660
[TBL] [Abstract][Full Text] [Related]
39. [Tests for prostate-derived enzymes. B. Immunochemical analysis of serum PAP and its clinical significance].
Koiso K; Nemoto R; Ishikawa S; Uchida K
Rinsho Byori; 1986 Jul; 34 Spec No 68():42-9. PubMed ID: 3531635
[No Abstract] [Full Text] [Related]
40. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
Stamey TA; Ekman PE; Blankenstein MA; Cooper EH; Kontturi M; Lilja H; Oesterling JE; Stenman UH; Turkes A
Scand J Urol Nephrol Suppl; 1994; 162():73-87; discussion 115-27. PubMed ID: 7529430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
